Belong.Life

Founded in 2015 by Eliran Malki, Irad Deutsch, and Ohad Rubin, Belong.Life is a digital health company developing AI social networking platforms and clinical trial matching software for patients managing chronic diseases. The Tel Aviv, Israel-based enterprise provides free consumer applications for peer support and expert medical access while generating revenue through patient engagement SaaS platforms and anonymized data insights. Serving over one million active users across more than 100 countries, the company focuses primarily on oncology, multiple sclerosis, and inflammatory bowel disease. Belong.Life has raised approximately $36 million in total venture funding, securing financial backing and strategic partnerships from organizations such as IQVIA and The Group Ventures. Recently, the firm introduced conversational AI mentors named Tara and Dave, and its Smart Clinic AI won a clinical automation innovation award from Clinical Trials Arena.

High-Level Overview

Belong.Life is a digital health company that builds AI-powered patient engagement platforms, including the world's largest social and professional networks for cancer (*Belong – Beating Cancer Together*) and multiple sclerosis (*BelongMS*), as well as tools like *Dave* (AI Cancer Mentor), *Tara* for clinical trial matching, and the *i-Belong* SaaS platform for customizable patient communities.[1][3][5] It serves patients with chronic diseases, caregivers, healthcare organizations (hospitals, clinics, payers, pharma), and advocacy groups by solving key challenges in patient support: lack of reliable information, emotional isolation, care coordination, and access to clinical trials through 24/7 AI mentors, peer communities, personalized education, and real-world data insights.[1][2][3][5] The company demonstrates strong growth momentum via platform expansions like *i-Belong* (launched 2021) and advanced GenAI solutions, positioning it as a leader in elevating patient outcomes globally.[1][3][5]

Origin Story

Belong.Life was founded by individuals personally affected by cancer, as each founder's family members battled the disease; they struggled to find reliable medical information or supportive communities during their caregiving roles, sparking the idea for a personalized app to address practical and emotional needs.[1] This catalyst led to the creation of *Belong – Beating Cancer Together*, the company's first platform, now the world's largest social and professional network for cancer management.[1][3] Key milestones include launching *BelongMS* for multiple sclerosis, *BelongIBD* (in select countries), *CoronApp*, and in August 2021, *i-Belong*—a SaaS solution enabling healthcare players to build self-managed communities on a pay-as-you-grow model—along with AI innovations like *Dave*.[1][3][5][6] These developments evolved Belong.Life from a cancer-focused app to a comprehensive provider of disease-specific networks and enterprise tools.[1][3]

Core Differentiators

• AI-Driven Personalization: Proprietary health-grade AI (e.g., *Dave – Cancer Mentor*, *Tara*) delivers 24/7 proactive support, triaging, clinical trial matching, and physician-validated guidance, integrated with peer communities for hyper-personalized patient journeys.[1][3][5][6]
• Largest Disease-Specific Networks: Operates the world's biggest social/professional communities for cancer and MS, plus others like *BelongIBD*, fostering engagement, education, and real-world data for research.[1][3][5]
• SaaS Flexibility for Enterprises: *i-Belong* allows providers, payers, pharma, and NGOs to create customizable, self-managed communities with Belong's tech stack, subscription pricing, and management features for scalable patient support.[1][3]
• End-to-End Ecosystem: Combines communities, AI mentors, medical binders for record organization, professional access, and actionable insights on patient trends, outperforming generic tools in engagement and outcomes.[3][5]

Role in the Broader Tech Landscape

Belong.Life rides the wave of GenAI in healthcare and rising demand for patient-centric digital health amid chronic disease prevalence (e.g., cancer, MS), where traditional care gaps leave patients underserved.[1][5] Timing aligns with post-pandemic shifts toward remote, data-driven support and regulatory pushes for real-world evidence, amplified by AI advancements enabling secure, validated tools like ARCH guardrails.[5] Market forces favoring it include exploding digital health investments, payer/pharma needs for efficient engagement, and patient preference for peer-validated AI over siloed apps.[3][5] It influences the ecosystem by providing quality real-world data to researchers, streamlining care coordination for organizations, and setting benchmarks for ethical AI in patient empowerment, potentially accelerating global outcomes in personalized medicine.[1][5]

Quick Take & Future Outlook

Belong.Life is poised to expand its GenAI portfolio with more disease-specific mentors and deeper integrations for hospitals/pharma, capitalizing on AI's maturation for predictive care and trial acceleration.[5][6] Trends like interoperable health data standards and value-based care will propel its growth, evolving it from community builder to indispensable analytics partner amid rising chronic illness burdens. As digital health matures, Belong.Life's founder-driven focus on lived experience could redefine patient engagement, turning isolated journeys into connected, empowered ecosystems—echoing its origins in bridging information voids for cancer families.[1][5]